Skip to main content

The new normal...

Somebody said it has been 12 weeks now since 'lockdown' started and our labs stopped being our workplace (I have to admit that I never really started counting, just couldn't see the point). Is that a long time or not that long? I know I have got some things done, and others have stubbornly refused to leave my (home) desk despite serious efforts. There have been many lovely things happening, a couple of really exciting new collaborative applications. Some excellent work from the group who have been magnificent in their ability to take this all in their stride. Our final year vets have all passed their exams in unpredictable circumstances! Personally I have had the wonderful experience of having both my sons at home with me for some time when I had previously worried that the empty nest was my next chapter.
The labs are gradually being re-tuned to be functional and much deliberation and preparation has been going into the process of returning to research in a Covid19 compliant manner - described obliquely as 'new ways of working'. The upshot is that labwork will need to be planned and very focused with limited time-slots available for  these types of activities. I imagine as with most things this will become routine and acceptable. For those of us who routinely spent every waking hour in the lab as PhD students and postdocs it does seem like our world has undergone a significant remodel.

Comments

Post a Comment

Popular posts from this blog

New research by a Nottingham academic linking the neurodegenerative disease Parkinson’s to changes in a protein in brain mitochondria is to receive support from a prestigious US funding agency. Dr Lisa Chakrabarti, at The University of Nottingham, will receive $75,000 for a one-year research project from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which is dedicated to finding a cure for Parkinson’s and funds promising research that could result in new treatments to slow, stop or reverse the progression of the disease. Dr Chakrabarti said: “We are trying to look at mitochondrial biology from a totally different perspective, which could have important implications for Parkinson’s and other neurodegenerative diseases. The funding from The Michael J. Fox Foundation will help us to confirm whether some of the protein changes we see in Parkinson’s are related to disease course.” http://exchange.nottingham.ac.uk/research/parkinsons-study-receives-fu...
Post a Comment
Read more

Some impressions from the expedition

 
Post a Comment
Read more

Katie and Jacob presented their work at the European Drosophila Research Conference in Alicante - September 25th-28th 2025

EDRC 2025 Alicante   Using a CaFe assay to assess mitochondrial function in olanzapine treated D.melanogaster.  Katherine Mortimer  'The EDRC 2025 brought together researchers from a diverse range of disciplines with a shared interest in using Drosophila melanogaster as a biological model. For that reason, I thoroughly enjoyed the poster session. I had lots of interesting conversations pertaining to all areas of my poster, from specific methodology to a general interest in mitochondria. I found myself chatting to people for the whole 2-hour session and walking away with lots of useful insights and connections. ' Quantum Sensing of Mitochondrial Physiology in Response to a Hypomagnetic Field. Jacob Reed 'It was great to be surrounded by researchers from around the world at the 28th EDRC, all sharing a passion for Drosophila. I especially enjoyed the talks on metabolism and mitochondria, which led to insightful conversations on mito-nuclear DNA mismatch. Presentin...
Post a Comment
Read more